LifePoint Health (LPNT) – Analysts’ Recent Ratings Updates

Several brokerages have updated their recommendations and price targets on shares of LifePoint Health (NASDAQ: LPNT) in the last few weeks:

  • 11/2/2017 – LifePoint Health is now covered by analysts at Credit Suisse Group AG. They set a “neutral” rating and a $54.00 price target on the stock.
  • 10/31/2017 – LifePoint Health had its “outperform” rating reaffirmed by analysts at Leerink Swann. They now have a $58.00 price target on the stock, down previously from $74.00. They noted that the move was a valuation call. They noted that the move was a valuation call.
  • 10/31/2017 – LifePoint Health was given a new $54.00 price target on by analysts at SunTrust Banks, Inc.. They now have a “hold” rating on the stock.
  • 10/31/2017 – LifePoint Health was downgraded by analysts at Zacks Investment Research from a “hold” rating to a “sell” rating. According to Zacks, “LifePoint Health’s third-quarter earnings missed the Zacks Consensus Estimate and declined year over year due to weak patient admissions. The stock has underperformed the industry in a year’s time. The company also trimmed its 2017 guidance for the second time on a challenging volume environment and weak revenue growth. The company is faced with increasing expenses which has outpaced revenue growth thereby squeezing operating margins. High bad debt is another concern as is declining cash flows. However, the company’s inorganic growth strategies have aided its overall growth. Disciplined share buyback also provides support to its bottom line.”
  • 10/30/2017 – LifePoint Health was given a new $55.00 price target on by analysts at Robert W. Baird. They now have a “buy” rating on the stock.
  • 10/30/2017 – LifePoint Health had its “market perform” rating reaffirmed by analysts at Raymond James Financial, Inc..
  • 10/30/2017 – LifePoint Health had its price target lowered by analysts at Royal Bank Of Canada to $65.00. They now have an “outperform” rating on the stock.
  • 10/30/2017 – LifePoint Health had its price target lowered by analysts at Citigroup Inc. from $70.00 to $60.00. They now have a “buy” rating on the stock.
  • 10/30/2017 – LifePoint Health had its price target lowered by analysts at BMO Capital Markets from $59.00 to $55.00. They now have a “market perform” rating on the stock.
  • 10/29/2017 – LifePoint Health had its “hold” rating reaffirmed by analysts at KeyCorp.
  • 10/27/2017 – LifePoint Health was given a new $50.00 price target on by analysts at Mizuho. They now have a “hold” rating on the stock.
  • 10/16/2017 – LifePoint Health is now covered by analysts at BMO Capital Markets. They set a “market perform” rating and a $59.00 price target on the stock.
  • 10/12/2017 – LifePoint Health was given a new $69.00 price target on by analysts at Robert W. Baird. They now have a “buy” rating on the stock.
  • 10/12/2017 – LifePoint Health was given a new $60.00 price target on by analysts at SunTrust Banks, Inc.. They now have a “hold” rating on the stock.
  • 10/4/2017 – LifePoint Health had its “hold” rating reaffirmed by analysts at Piper Jaffray Companies. They now have a $66.00 price target on the stock.
  • 10/3/2017 – LifePoint Health was downgraded by analysts at Zacks Investment Research from a “hold” rating to a “sell” rating. According to Zacks, “LifePoint Health’s stock has underperformed the industry in last three months. The company is faced with increasing expenses which has outpaced revenue growth thereby squeezing operating margins. The company is suffering from low patient admissions. High bad debt is another concern. Following second-quarter results, the company trimmed its 2017 guidance on a challenging volume environment and weak revenue growth. The stock has seen the Zacks Consensus Estimate for current-year earnings being revised 2.9% downward over the last 60 days.”

LifePoint Health, Inc. (NASDAQ:LPNT) traded up $0.30 on Tuesday, hitting $44.50. The company had a trading volume of 463,500 shares, compared to its average volume of 419,369. The firm has a market cap of $1,742.18, a PE ratio of 11.28, a P/E/G ratio of 1.15 and a beta of 0.68. The company has a current ratio of 1.85, a quick ratio of 1.65 and a debt-to-equity ratio of 1.24. LifePoint Health, Inc. has a 1-year low of $43.30 and a 1-year high of $70.95.

LifePoint Health (NASDAQ:LPNT) last released its quarterly earnings results on Friday, October 27th. The company reported $0.80 earnings per share for the quarter, missing analysts’ consensus estimates of $0.95 by ($0.15). The firm had revenue of $1.58 billion during the quarter, compared to analyst estimates of $1.60 billion. LifePoint Health had a return on equity of 7.01% and a net margin of 2.45%. The business’s revenue was down .7% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.94 EPS. equities analysts expect that LifePoint Health, Inc. will post 3.65 earnings per share for the current fiscal year.

LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.

Receive News & Ratings for LifePoint Health Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply